The use of antimicrobials (AMs) in pediatric infections is common practice and use may be inappropriate leading to antimicrobial resistance. Off-label AM use is also common in this group and can result in drug-related problems. There is lack of DUR data in Brazil and in Latin America, specially for AM pediatric use.
View Article and Find Full Text PDFIntroduction: Adverse drug reactions (ADRs) to anti-infectives affect especially hospitalized children and contribute to increased morbidity, mortality, length of stay, and costs in healthcare systems.
Objective: To assess ADRs associated with anti-infective use in Brazilian hospitalized children.
Methods: A prospective cohort study was conducted in 5 public hospitals over 6 months.